Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06549348

Radiation Free Study

Led by Philips Clinical & Medical Affairs Global · Updated on 2025-09-05

182

Participants Needed

9

Research Sites

51 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a prospective, randomized, unblinded, multi-center study. Sites were selected from different geographies (EU and US) with different clinical practice to ensure the results are more generalizable. Primary objective is to demonstrate that the average procedure fluoroscopy time using LumiGuide is lower compared to conventional fluoroscopy guidance in Fenestrated Endovascular Aortic Repair (FEVAR)

CONDITIONS

Official Title

Radiation Free Study

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Subject will be undergoing a primary Fenestrated Endovascular Aortic Repair (FEVAR) procedure including visceral artery incorporation
  • Subject is 18 years of age or older or legally able to give informed consent
  • Subject has a life expectancy of at least 2 years
  • Target vessels to be included are the Celiac Trunk, Superior Mesenteric Artery, and Renal Arteries
Not Eligible

You will not qualify if you...

  • Subjects undergoing an endovascular procedure including branches or iliac branched devices
  • Subject treated for re-intervention or staged procedure post-primary FEVAR
  • Subjects intended to be treated for more than 4 target vessels (excluding contralateral gate)
  • Subject treated for an emergent procedure within 24 hours after emergence
  • Subject with connective tissue disorders such as Marfan's or Ehlers Danlos Syndrome
  • Subject with contrast allergies
  • Subject participating in confounding drug or device trials without Philips pre-approval
  • Vulnerable subjects including immuno-compromised, lacking consent capacity, emergency patients, pregnant or breastfeeding women
  • Subject unwilling or unable to comply with protocol or provide informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 9 locations

1

University of Alabama

Birmingham, Alabama, United States, 35249

Not Yet Recruiting

2

University of Massachusetts

Worcester, Massachusetts, United States, 01655

Actively Recruiting

3

University of Pennsylvania

Philadelphia, Pennsylvania, United States, 19104

Actively Recruiting

4

University of Texas Southwestern Medical Center

Dallas, Texas, United States, 75390

Actively Recruiting

5

UZ Gent

Ghent, Belgium

Not Yet Recruiting

6

Rigshospitalet University Hospital

Copenhagen, Denmark

Not Yet Recruiting

7

Hôpital Universitaire Pitié-Salpêtrière

Paris, France

Not Yet Recruiting

8

UMC Maastricht

Maastricht, Netherlands

Not Yet Recruiting

9

Guys & St Thomas

London, United Kingdom

Not Yet Recruiting

Loading map...

Research Team

B

Bart Wessels

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here